Eptinezumab-jjmr, a humanized monoclonal specific to Calcitonin Gene Related Peptide, for the preventive treatment of migraine in adults
# Purpose of Review Migraines are prevalent and cause significant morbidity, decline in quality of life and healthcare costs universally. Treatment options are varied, but efficacy is limited. This review centers on Eptinezumab-jjmr, a humanized monoclonal specific to CGRP for the prevention of mig...
Saved in:
Main Authors: | Amnon A. Berger, Joseph Keefe, Cain W. Stark, Matthew Moore, Giovanni F. Ramírez, Julia R. Cucarola, Andrew H. Han, Alan D. Kaye, Latha Ganti |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Medical Publishing
2022-11-01
|
Series: | Health Psychology Research |
Online Access: | https://doi.org/10.52965/001c.38439 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New specific migraine prevention: monoclonal antibodies against calcitonin gene-related peptide and its receptor
by: K. Ryliškienė, et al.
Published: (2019-12-01) -
Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis
by: Daiki Tokuyasu, et al.
Published: (2025-01-01) -
Correction: Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis
by: Daiki Tokuyasu, et al.
Published: (2025-01-01) -
Rimegepant for the treatment of migraine
by: Amnon A. Berger, et al.
Published: (2022-10-01) -
The Effect of Calcitonin Gene-Related Peptide Monoclonal Antibodies on Quality of Life among Migraine Patients: Pilot Study at the Hospital of Lithuanian University of Health Sciences Kaunas Clinics
by: Monika Remenčiūtė, et al.
Published: (2024-05-01)